IL17A and tuberculosis: MAIT cells show therapeutic potential for tuberculosis due to their ability to recognize Mtb antigens and produce pro-inflammatory cytokines (e.g., IFN-γ, TNF-α, IL-17A), which enhance antimycobacterial immunity.